CD19 Car T Therapy In Children with R/R All: Adaptive Split Dosing Improves Safety and Maintains Efficacy of the Approach

被引:0
|
作者
Molostova, Olga [1 ]
Shelikhova, Larisa [1 ]
Muzalevsky, Yakov [1 ]
Kazachenok, Alexey [1 ]
Khismatullina, Rimma [1 ]
Abugova, Julia [1 ]
Kurnikova, Elena [1 ]
Trakhtman, Pavel [1 ]
Balashov, Dmitry [1 ]
Pershin, Dmitriy [1 ]
Zubachenko, Viktoria [1 ]
Fadeeva, Maria [1 ]
Popov, Alexander [1 ]
Illarionova, Olga [1 ]
Rauser, Georg [2 ]
Alex, Regina [2 ]
Dropulic, Boro [3 ]
Orentas, Rimas [3 ]
Shneider, Dina [3 ]
Miakova, Natalia [1 ]
Litvinov, Dmitry [1 ]
Novichkova, Galina [1 ]
Maschan, Alexey [1 ]
Maschan, Michael [1 ]
机构
[1] Dmitriy Rogachev Natl Med Ctr Pediat Hematol, Oncol & Immunol, Moscow, Russia
[2] Miltenyi Biotec GmbH, Bergisch Gladbach, Germany
[3] Lentigen, Gaithersburg, MD USA
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
O026
引用
收藏
页码:36 / 36
页数:1
相关论文
共 50 条
  • [1] Efficacy and influencing factors of CD19 CAR-T cell therapy for children and adults with r/r B-ALL
    An, F.
    Liu, Z.
    Wu, F.
    Wang, H.
    Zhang, J.
    Cheng, F.
    Tao, Q.
    Li, Y.
    Shen, Y.
    Ruan, Y.
    Zhang, Q.
    Pan, Y.
    Zhu, W.
    Wang, W.
    Xu, H.
    Qin, H.
    Wang, Y.
    Feng, Z.
    Song, X.
    Zhai, Z.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1717 - 1717
  • [2] Efficacy and safety of bendamustine-containing bridging therapy in R/R LBCL patients receiving CD19 CAR T-cells
    Iacoboni, Gloria
    Sanchez-Salinas, Mario A.
    Rejeski, Kai
    Martin-Lopez, Ana a.
    Kwon, Mi
    Navarro, Victor
    Jalowiec, Katarzyna A.
    Hernani, Rafael
    Reguera-Ortega, Juan L.
    Gallur, Laura
    Blumenberg, Viktoria
    Herrero-Garcia, Maria
    Roddie, Claire
    Benzaquen, Ana
    Delgado-Serrano, Javier
    Bailen, Rebeca
    Carpio, Cecilia
    Amat, Paula
    Lopez-Corral, Lucia
    Martin-Martin, Lourdes
    Bastos, Mariana
    Subklewe, Marion
    O'Reilly, Maeve
    Barba, Pere
    [J]. HEMASPHERE, 2024, 8 (07):
  • [3] Feasibility and safety of a novel CD19 CAR T cell therapy in adults with R/R B-NHL.
    Kamdar, Manali
    Adams, Cheri
    Bair, Steven
    Dropulic, Boro
    Gutman, Jonathon
    Haverkos, Bradley
    Jordan, Kimberly
    Mallo, Rebecca
    Marians, Russell
    Mast, Felicia
    Murphy, Lindsey
    Roth, Andrew
    Seefeldt, Matthew
    Worden, Andrew
    Kadan, Mike
    Xiong, Ying
    Schneider, Dina
    Orentas, Rimas
    Fry, Terry
    Verneris, Michael
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [4] Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapy
    Wenjie Li
    Lixia Ding
    Wenhua Shi
    Xinyu Wan
    Xiaomin Yang
    Jing Yang
    Tianyi Wang
    Lili Song
    Xiang Wang
    Yani Ma
    Chengjuan Luo
    Jingyan Tang
    Longjun Gu
    Jing Chen
    Jun Lu
    Yanjing Tang
    Benshang Li
    [J]. Journal of Translational Medicine, 21
  • [5] Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapy
    Li, Wenjie
    Ding, Lixia
    Shi, Wenhua
    Wan, Xinyu
    Yang, Xiaomin
    Yang, Jing
    Wang, Tianyi
    Song, Lili
    Wang, Xiang
    Ma, Yani
    Luo, Chengjuan
    Tang, Jingyan
    Gu, Longjun
    Chen, Jing
    Lu, Jun
    Tang, Yanjing
    Li, Benshang
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [6] Efficacy and safety of humanized CD19 CAR-T as a salvage therapy for recurrent CNSL of B-ALL following murine CD19 CAR-T cell therapy
    Li, Xin
    Liu, Mei-Jing
    Mou, Nan
    Yang, Zhen-Xing
    Wang, Jia
    Mu, Juan
    Zhu, Hai-Bo
    Deng, Qi
    [J]. ONCOLOGY LETTERS, 2021, 22 (05)
  • [7] IKAROS MEDIATES ANTIGEN ESCAPE FOLLOWING CD19 CAR T CELL THERAPY IN R/R B-ALL
    Domizi, Pablo
    Sarno, Jolanda
    Jager, Astraea
    Rotiroti, Maria Caterina
    Baskar, Reema
    Reynolds, Warren
    Sahaf, Bita
    Bendall, Sean
    Mullighan, Charles
    Leahy, Allison
    Myers, Regina
    Grupp, Stephan
    Majzner, Robbie
    Sotillo, Elena
    Barrett, David
    Davis, Kara
    [J]. PEDIATRIC BLOOD & CANCER, 2022, 69
  • [8] Ikaros Mediates Antigen Escape Following CD19 CAR T Cell Therapy in r/r B-ALL
    Domizi, Pablo
    Sarno, Jolanda
    Jager, Astraea
    Baskar, Reema
    Reynolds, Warren D.
    Sahaf, Bita
    Bendall, Sean
    Mullighan, Charles G.
    Leahy, Allison Barz
    Myers, Regina M.
    Grupp, Stephan A.
    Sotillo, Elena
    Barrett, David
    Davis, Kara L.
    [J]. BLOOD, 2021, 138
  • [9] Quantification of ADA of Humanized CD19 CAR-T Cell Therapy in R/R LBCL
    Huang, Zhongpei
    Mei, Heng
    Li, Chenggong
    Hu, Yu
    [J]. BLOOD, 2023, 142
  • [10] Safety and efficacy of CD19/CD22 CAR T cells in children and young adults with relapsed/refractory ALL
    Shalabi, Haneen
    Yates, Bonnie
    Shahani, Shilpa
    Qin, Haiying
    HIghfill, Steven L.
    Panch, Sandhya
    Tran, Minh
    Stroncek, David
    Hoffman, Leah
    Little, Lauren
    Graap, Katherine
    Stetler-Stevenson, Maryalice
    Yuan, Constance
    Wang, Hao-Wei
    Fry, Terry J.
    Shah, Nirali N.
    [J]. CANCER RESEARCH, 2020, 80 (16)